The 1 analysts offering 12-month price forecasts for PainReform Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +445.45% increase from the last price of 1.10.
The current consensus among 1 polled investment analysts is to Buy stock in PainReform Ltd. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.55
Reporting Date Mar 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.